Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Malkiel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|August 10, 2016
DNA-reactive B cells in lupusJolien Suurmond, Justine Calise, Susan Malkiel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease BorreliaSusan Malkiel, Christopher J Kuhlow, Patricio Mena, et al.
Frontiers in Immunology|March 21, 2018
Plasma Cell Differentiation Pathways in Systemic Lupus ErythematosusSusan Malkiel, Ashley N Barlev, Yemil Atisha-Fregoso, et al.
The Journal of Clinical Investigation|July 12, 2022
FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activationAshley N Barlev, Susan Malkiel, Izumi Kurata-Sato, et al.
Lupus Science & Medicine|May 18, 2023
B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy childrenJoyce Hui-Yuen, Kaiyu Jiang, Susan Malkiel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow CytometrySusan Malkiel, Venkatesh Jeganathan, Stacey Wolfson, et al.
JCI Insight|February 1, 2022
Context-dependent induction of autoimmunity by TNF signaling deficiencyTam D Quach, Weiqing Huang, Ranjit Sahu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus NephritisYemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|August 10, 2016
DNA-reactive B cells in lupusJolien Suurmond, Justine Calise, Susan Malkiel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease BorreliaSusan Malkiel, Christopher J Kuhlow, Patricio Mena, et al.
Frontiers in Immunology|March 21, 2018
Plasma Cell Differentiation Pathways in Systemic Lupus ErythematosusSusan Malkiel, Ashley N Barlev, Yemil Atisha-Fregoso, et al.
The Journal of Clinical Investigation|July 12, 2022
FcγRIIB regulates autoantibody responses by limiting marginal zone B cell activationAshley N Barlev, Susan Malkiel, Izumi Kurata-Sato, et al.
Lupus Science & Medicine|May 18, 2023
B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy childrenJoyce Hui-Yuen, Kaiyu Jiang, Susan Malkiel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow CytometrySusan Malkiel, Venkatesh Jeganathan, Stacey Wolfson, et al.
JCI Insight|February 1, 2022
Context-dependent induction of autoimmunity by TNF signaling deficiencyTam D Quach, Weiqing Huang, Ranjit Sahu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus NephritisYemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
Pageof 1